#Growth Strategy #Lumission #Company Diagnosis

The Launch of the 10 Billion Company Roadmap Diagnosis

Lumission Inc., based in Minato City, Tokyo, is excited to announce the launch of its new service, the "10 Billion Company Roadmap Diagnosis," set to begin on June 22, 2026. This innovative program is designed specifically for small and growing companies aiming to scale their annual revenue from 1 billion to 10 billion yen.

This diagnosis aims to visualize the growth challenges businesses face as they navigate the complex landscape of expansion. Common hurdles include dependency on the CEO for decisions, stagnation of organizational growth, and uncertainty about where to invest next. As businesses typically encounter unique challenges at each revenue milestone, it becomes increasingly critical to identify and address these issues as they transition from 1 billion to 10 billion yen in revenue.

Understanding the Need for Diagnosis

As companies grow, various operational and strategic issues present themselves. Around the 1 billion yen mark, companies often reach a tipping point. Decisions that previously rested on the CEO's shoulders or were managed on the ground become more intricate, leading to challenges in organizational expansion, executive training, delegation of authority, profit management, and new business development. However, many companies struggle to objectively understand where they are stalling in their growth trajectories.

Recognizing this challenge, Lumission believes the essence of these issues lies not in isolated problems but rather in a lack of strategic management design necessary for advancing to the next growth stage. Consequently, the new "10 Billion Company Roadmap Diagnosis" was developed to map out the critical management issues and improvement themes essential for achieving the 10 billion mark.

Key Features of the 10 Billion Company Roadmap Diagnosis

This service provides a comprehensive analysis of several crucial factors that contribute to business growth:

• - Product design
• - Customer acquisition structure
• - Sales systems
• - Profit structure
• - Organizational framework
• - Recruitment capabilities
• - Executive training
• - Delegation of authority
• - New business ventures
• - Management strategy

By conducting this analysis, businesses will receive insights that clarify:

• - Growth bottlenecks
• - Current stage in the growth process
• - Differences from 10 billion yen companies
• - Prioritized management challenges
• - Specific actions to take next

Complimentary Growth Strategy Material

Participants in the diagnosis will receive a complimentary resource titled "Roadmap from 1 Billion to 10 Billion Yen." This guide includes:

• - Steps for growth
• - Challenges faced during organizational expansion
• - Approaches to executive training
• - Designing delegation of authority
• - Improving profit structure
• - New business design
• - Prioritizing growth investments

What Can the Diagnosis Reveal?

By engaging in this process, business owners will uncover the true causes of growth stagnation, the necessary conditions to evolve into a 10 billion yen entity, and gain clarity around the reasons for dependency on the CEO and why organizational expansion is not occurring. Furthermore, participants will identify the primary growth themes that demand immediate attention.

Growth is not simply a matter of determination; it hinges on strategically designed frameworks tailored to each growth stage.

Why Offer This Service for Free?

Lumission is not merely focused on boosting revenues; it emphasizes sustainable growth through effective management design. The company advocates a unique management philosophy termed "5-Way Good Management," which aims to create value for all stakeholders, including the company, employees, customers, society, and future generations. To facilitate this, the diagnosis is being offered free of charge, allowing businesses to assess their growth challenges meaningfully.

The Concept of